BASEL, Switzerland, Nov. 13 -- Liver Cancer, a peer-reviewed journal that says it focuses on molecular carcinogenesis, prevention, surveillance, diagnosis and treatment, including molecular targeted therapy of the disease, published research articles on the following topics in its October 2024 edition (Vol. 13, Issue 5):

* Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT
. . .

Click here for more information about our products